BIO.B
Bio-Rad Laboratories B·NYSE
--
--(--)
--
--(--)
6.20 / 10
Outperform
Fund flow evaluation is positive (6.2/10), showing net inflows across small, medium, and large blocks, indicative of underlying buying interest. Although overall and block trends lean negative, the positive directional flow at smaller scales suggests accumulation. No analyst ratings were available, leaving the sentiment primarily driven by money flow and news.
Fund Flow Rating
What is the analyst consensus for BIO.B?
- BIO.B holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.20/10 (Outperform).
